casimiroin
Identification
| Name | casimiroin |
| CAS Number | 477-89-4 |
| FDA UNII | 1X2A1U6BH3 |
| Molecular Formula | C12 H11 N O4 |
| Molecular Weight | 233.22347000 |
| Nikkaji Number | J6.143C |
Regulatory
Physical Properties
| Assay | 95.00 to 100.00 |
| Food Chemicals Codex Listed | No |
| Soluble in | water, 1.095e+004 mg/L @ 25 °C (est) |
No sensory data available
Safety Information
| Oral/Parenteral Toxicity | Not determined |
| Dermal Toxicity | Not determined |
| Inhalation Toxicity | Not determined |
GHS Classification
['GHS Classification in accordance with 29 CFR 1910 (OSHA HCS)', 'GHS Label elements, including precautionary statements']
Safety in Use
| Category | natural substances and extractives |
| Recommendation for casimiroin usage levels up to | not for fragrance use. |
| Recommendation for casimiroin flavor usage levels up to | not for flavor use. |
No supplier data available
Potential Uses
Natural Occurrence
Synonyms
1,3-
dioxolo(4,5-h)quinolin-8(9H)-one, 6-methoxy-9-methyl-
6-
methoxy-9-methyl-(1,3)dioxolo(4,5-h)quinolin-8(9H)-one
6-
methoxy-9-methyl-[1,3]dioxolo[4,5-h]quinolin-8-one
PubMed:
Vasorelaxation by extracts of Casimiroa spp. in rat resistance vessels and pharmacological study of cellular mechanisms.
PubMed:
Synthesis of carbon-11-labeled casimiroin analogues as new potential PET agents for imaging of quinone reductase 2 and aromatase expression in breast cancer.
PubMed:
Synthesis of casimiroin and optimization of its quinone reductase 2 and aromatase inhibitory activities.